Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xtant Medical Holdings (XTNT) Long-Term Debt Repayments (2016 - 2021)

Xtant Medical Holdings (XTNT) has disclosed Long-Term Debt Repayments for 12 consecutive years, with -$73000.0 as the latest value for Q3 2021.

  • On a quarterly basis, Long-Term Debt Repayments fell 282.5% to -$73000.0 in Q3 2021 year-over-year; TTM through Dec 2021 was $411000.0, a 30.48% increase, with the full-year FY2021 number at $411000.0, up 30.48% from a year prior.
  • Long-Term Debt Repayments was -$73000.0 for Q3 2021 at Xtant Medical Holdings, down from $176000.0 in the prior quarter.
  • In the past five years, Long-Term Debt Repayments ranged from a high of $308000.0 in Q1 2021 to a low of -$115000.0 in Q4 2017.
  • A 5-year average of $85684.2 and a median of $88000.0 in 2018 define the central range for Long-Term Debt Repayments.
  • Biggest YoY gain for Long-Term Debt Repayments was 805.88% in 2021; the steepest drop was 282.5% in 2021.
  • Xtant Medical Holdings' Long-Term Debt Repayments stood at -$115000.0 in 2017, then skyrocketed by 186.09% to $99000.0 in 2018, then tumbled by 39.39% to $60000.0 in 2019, then soared by 233.33% to $200000.0 in 2020, then plummeted by 136.5% to -$73000.0 in 2021.
  • Per Business Quant, the three most recent readings for XTNT's Long-Term Debt Repayments are -$73000.0 (Q3 2021), $176000.0 (Q2 2021), and $308000.0 (Q1 2021).